WealthPlan Investment Management LLC Makes New $256,000 Investment in Oscar Health, Inc. (NYSE:OSCR)

Key Points

• WealthPlan Investment Management LLC has made a new investment of $256,000 in Oscar Health, purchasing 19,524 shares during the first quarter.
• Oscar Health recently reported a quarterly loss of $0.89 earnings per share, surpassing analysts' expectations of a $0.90 loss, while revenue increased by 29% year-over-year.
• Analysts have generally downgraded Oscar Health's stock, with five maintaining a sell rating and others reducing their price targets significantly.

WealthPlan Investment Management LLC bought a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 19,524 shares of the company's stock, valued at approximately $256,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. grew its holdings in Oscar Health by 3.7% during the 1st quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company's stock valued at $258,247,000 after buying an additional 700,469 shares during the last quarter. Deerfield Management Company L.P. Series C lifted its position in Oscar Health by 50.7% during the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock worth $159,062,000 after buying an additional 3,983,325 shares during the period. Thrive Capital Management LLC lifted its position in Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after buying an additional 1,588,395 shares during the period. Gilder Gagnon Howe & Co. LLC boosted its stake in Oscar Health by 51.4% in the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock worth $85,154,000 after buying an additional 2,151,256 shares during the last quarter. Finally, BIT Capital GmbH grew its holdings in Oscar Health by 1.1% in the first quarter. BIT Capital GmbH now owns 4,521,445 shares of the company's stock valued at $59,276,000 after purchasing an additional 47,592 shares during the period. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the sale, the director directly owned 64,512 shares of the company's stock, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 24.39% of the stock is owned by corporate insiders.

Oscar Health Stock Up 5.6%

Shares of NYSE:OSCR opened at $15.15 on Friday. The company has a market capitalization of $3.86 billion, a price-to-earnings ratio of -18.70 and a beta of 1.86. The company has a 50 day moving average of $15.87 and a two-hundred day moving average of $14.86. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.79. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.22.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, beating analysts' consensus estimates of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.75%. The business had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.88 billion. During the same period last year, the business earned $0.20 EPS. The business's revenue was up 29.0% on a year-over-year basis. As a group, analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Piper Sandler downgraded Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price objective for the company. in a report on Monday, July 14th. Robert W. Baird restated a "neutral" rating and set a $14.00 price target (down from $28.00) on shares of Oscar Health in a research note on Friday, July 25th. Baird R W lowered Oscar Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 25th. Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Finally, Barclays cut their price target on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a report on Wednesday, July 23rd. Five analysts have rated the stock with a sell rating and five have issued a hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $12.21.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.